Although some carcinoma cell lines were resistant to direct anti-carcinoma activity of Gal-9 [9], we identified previously that all cell lines responded to Gal-9 treatment with surface-exposure of phosphatidylserine (PS), an important “eat me” signal for innate immune cells. The gene discussed is LGALS9; the disease is carcinoma.